Sorted By:

Relevance


Protect Your Health: Important Disaster Preparedness Tips for Harvey and Irma

PhRMA  |  Blog Post

But these tips, and other resources from Healthcare Ready, can prevent future health complications and be the difference between life or death in the uncertain and dangerous environment of a natural disaster.
http://catalyst.phrma.org/protect-your-health-important-disaster-preparedness-tips-for-harvey-and-irma

Over 900 Biotechnology Medicines in Development, Targeting More than 100 Diseases

PhRMA  |  Press Release

  The practice of medicine has changed dramatically over the years through pioneering advances in biotechnology research and innovation, and patients continue to benefit from the treatments that are being developed.
https://www.phrma.org/press-release/over-900-biotechnology-medicines-in-development-targeting-more-than-100-diseases

Going boldly together: New advancements and new anniversaries

PhRMA  |  Blog Post

Each year we celebrated two birthdays – his real one on July 30 and his liver-versary on October 7.
http://catalyst.phrma.org/going-boldly-together-new-advancements-and-new-anniversaries

Are new hep C treatments cost effective? Doctors say answer is “a resounding yes”

PhRMA  |  Blog Post

” Click here to read to full article.
http://catalyst.phrma.org/are-new-hep-c-treatments-cost-effective-doctors-say-answer-is-a-resounding-yes

Learning from Patients to Develop Better Treatments

PhRMA  |  Graphic

These perspectives can inform evaluation of a medicine’s benefits and risks and provide the context for FDA’s regulatory decision making.
https://www.phrma.org/graphic/learning-from-patients-to-develop-better-treatments

New Report Shows More than 240 Immuno-Oncology Treatments in Development for Patients with Cancer

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
https://www.phrma.org/press-release/new-report-shows-more-than-240-immuno-oncology-treatments-in-development-for-patients-with-cancer

PhRMA Policy Solutions: Delivering Innovative Treatments to Patients

PhRMA  |  Codes & Guidelines

Addressing health care costs holistically, we can build a sustainable, science-based health care system that stems the growth of chronic disease and harnesses today’s hopes to discover tomorrow’s cures.
https://www.phrma.org

PhRMA, member companies and NIH create public-private partnership for immuno-oncology

PhRMA  |  Blog Post

PhRMA is proud to support PACT and is hopeful that bringing together scientists and researchers from the public and private sectors will provide solutions to some of the most difficult problems in the fight against cancer.
http://catalyst.phrma.org/phrma-member-companies-and-nih-create-public-private-partnership-for-immuno-oncology

Putting the bio in biotech: How Bay Area minds are powering biopharmaceutical innovation

PhRMA  |  Blog Post

For example, earlier this summer, Eli Lilly and Company announced the completion of a $90 million expansion of their .lilly.com/releasedetail.cfm?
http://catalyst.phrma.org/putting-the-bio-in-biotech-how-bay-area-minds-are-powering-biopharmaceutical-innovation

GSK and UNC-Chapel Hill announce novel partnership to accelerate search for HIV cure

From Hope To Cures  |  From Our Network

ViiV has significant clinical expertise and will play an advisory role to the HIV Cure center and Qura Therapeutics.
http://www.fromhopetocures.org/gsk-and-unc-chapel-hill-announce-novel-partnership-to-accelerate-search-for-hiv-cure

Scientists Honored With Discoverers Award For Development of Innovative HIV Medicine

PhRMA  |  Press Release

“The honorees’ vision, dedication and leadership played a critical role in helping our company develop a medicine that can help reduce the number of people who have to suffer and improve the health of HIV patients around the world.”
https://www.phrma.org/press-release/scientists-honored-with-discoverers-award-for-development-of-innovative-hiv-medicine

Celebrating tremendous advances in HIV/AIDS on National Youth HIV/AIDS Awareness Day

PhRMA  |  Blog Post

In the past 10 years, 15 new medicines have been approved – including three new entirely classes of therapy, as well as treatments which reduce pill burden by combining multiple antiretroviral treatments into a once-daily pill.
http://catalyst.phrma.org/celebrating-tremendous-advances-in-hiv/aids-on-national-youth-hiv/aids-awareness-day

Burden 2015 – HIV

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/burden-2015-hiv

The Challenge of Developing New Treatments and Cures

PhRMA  |  Video

Failure is an inherent part of this complex process; most medicines never make it through the pipeline.
https://www.phrma.org/video/the-challenge-of-developing-new-treatments-and-cures

Paving the Way for Better Cancer Treatments

PhRMA  |  Blog Post

Every patient has a unique story and just as no single cancer is exactly the same, treatments should be targeted to individuals and their distinct needs.
http://catalyst.phrma.org/paving-the-way-for-better-cancer-treatments

By the Numbers: HIV/AIDS Medicines Under Exchange Plans

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/by-the-numbers-hiv/aids-medicines-under-exchange-plans

The Challenge of Developing New Treatments and Cures

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/the-challenge-of-developing-new-treatments-and-cures

340B Then & Now

PhRMA  |  Graphic

A closer look at how the 340B program has evolved since its creation in 1992.
https://www.phrma.org/graphic/340b-then-and-now

Senior Manager – Policy and Research

PhRMA  |  PhRMA Career

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
https://www.phrma.org/careers/sr-manager-policy-and-research

Let's Talk About Cost

PhRMA  |  From PhRMA

Must-Know Facts About Medicine Costs and Spending: Download Here
https://www.phrma.org/advocacy/cost-and-value

Falling Death Rates for HIV/AIDS Patients

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/falling-death-rates-for-hiv/aids-patients

PhRMA Statement on Comments to CMS Regarding Proposed Part D Rule and RFI Exploring Pass-Through Rebates to Seniors at Point of Sale

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $65.5 billion in 2016 alone.
https://www.phrma.org/press-release/phrma-statement-on-comments-to-cms-regarding-proposed-part-d-rule-and-rfi-exploring-pass-through-rebates-to-seniors-at-point-of-sale

5 Ways Your Insurer May Prevent You From Getting Your Medicine

Access Better Coverage  |  From Our Network

If you find out that a medicine is not covered and you are not able to switch plans, you can ask to go through an exceptions process to gain coverage
http://www.accessbettercoverage.org/articles/5-ways-your-insurer-may-prevent-you-from-getting-your-medicine

5 ways your insurer may prevent you from getting your medicine

PhRMA  |  Blog Post

When deciding which insurance plan is best for you and your family, be sure to look carefully at howand if – the medicines you and your family need are covered.
http://catalyst.phrma.org/5-ways-your-insurer-may-prevent-you-from-getting-your-medicine

Burden on Patients: 5 Questions on Access to HIV/AIDS Medicines in Health Exchange Plans

PhRMA  |  Blog Post

HIV is very unique and every patient has different needs.
http://catalyst.phrma.org/burden-on-patients-5-questions-on-access-to-hiv/aids-medicines-in-health-exchange-plans

You have reviewed the first 50 results out of 2653. Each page contains 25 results. You're on page 2.

prev 1 2 3 4 5 6 next